RESNIBEN
pharmaceutical preparations for the treatment of cancer, pain, infection, inflammation, hormone disorders, bone disorders, and mental disorders; analgesics; hormones; psychotropics; anti-infectives; anti-inflammatories; anti-cancer preparations
Pending · April 30, 2025 · 99163806 ·